- Home
- MDCX vs VTGN Comparison
MDCX vs VTGN Comparison
Compare MDCX & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.64
Company Overview
Basic Information| Metric | MDCX | VTGN |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1M | 28.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDCX | VTGN |
|---|---|---|
| Price | $1.32 | $0.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $23.50 | $0.90 |
| AVG Volume (30 Days) | 279.5K | ★ 2.3M |
| Earning Date | 02-22-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $721,000.00 |
| Revenue This Year | N/A | $87.21 |
| Revenue Next Year | N/A | $256.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.31 | $0.63 |
| 52 Week High | $8.94 | $5.14 |
Technical Indicators
Market Signals| Indicator | MDCX | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 28.54 | 24.87 |
| Support Level | $1.31 | $0.66 |
| Resistance Level | $1.48 | $0.74 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 2.50 | 3.61 |
Price Performance
Historical Comparison MDCX
VTGN
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.